Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: U01 CA272610
NCI NIH HHS
Grant: R01 CA042978
NCI NIH HHS
Grant: R01 CA266558
NCI NIH HHS
Grant: T32 CA009156
NCI NIH HHS
Grant: T32 CA009140
NCI NIH HHS
Grant: U01 CA274312
NCI NIH HHS
Grant: U01 CA199235
NCI NIH HHS
Grant: R01 CA276268
NCI NIH HHS
Grant: T32 CA071341
NCI NIH HHS
Grant: R01 CA229803
NCI NIH HHS
Grant: P30 CA013696
NCI NIH HHS
Grant: P50 CA196510
NCI NIH HHS
Grant: U54 CA274506
NCI NIH HHS
Grant: R01 CA215607
NCI NIH HHS
Grant: P01 CA203657
NCI NIH HHS
Grant: R35 CA232113
NIH HHS
Grant: S10 OD032433
NIDDK NIH HHS
Grant: P30 DK132710
NCI NIH HHS
Grant: R01 CA175747
Fields of Study
Keywords
Sustainable Development Goals